Evogene is a world leading developer of improved plant traits, such as yield and drought tolerance, for a wide diversity of key crops through the use of plant genomics. The company focuses on utilizing its proprietary computational genomic technologies to provide a complete solution for plant trait improvement through combining state of the art biotechnology and advanced breeding methods. These technologies include ATHLETE™ for gene discovery; Gene2Product™ for improving trait efficacy and probability of successful development of biotechnology seed products; and EvoBreed™ for breeding enhancement. Evogene's plant genomics capabilities combine high throughput plant validation systems, field experiments and proprietary genomic data creation. Evogene is collaborating with world leading seed companies to introduce its improved plant traits into key commercial crops under milestone and royalty bearing agreements. Evogene's headquarters are in Rehovot, Israel, and its stock is traded on the Tel Aviv Stock Exchange (TASE: EVGN).
Evogene – a burst of growth
Evogene's unique capabilities primarily stem from our multi-disciplinary team of talented professionals, allowing for the creativity and flexibility of an innovative company combined with the resources and large scale operations required for delivery of our massive discoveries. Our team includes biologists, agronomists, technicians, imaging experts and more, each contributing to our versatility and innovation.